Lv71
5000 积分 2022-03-11 加入
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer
1小时前
已完结
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
17天前
已完结
Faricimab: First Approval
18天前
已完结
视网膜微血管中周细胞相关的信号通路
24天前
已完结
神经血管单元在视网膜生理及病理过程中的作用研究进展
24天前
已完结
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
24天前
已完结
Long-term outcomes of sequential chemotherapy in epithelioid sarcoma
1个月前
已完结
Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors
1个月前
已完结
Tazemetostat for Advanced Epithelioid Sarcoma: Current Status and Future Perspectives
1个月前
已完结
Tazemetostat for advanced epithelioid sarcoma: current status and future perspectives
1个月前
已完结
皖公网安备34019202002308
